New flow cytometry are equipped with multiple lasers and fluorescent markers to provide accurate diagnosis and aid to combat cancer and other health disorders

Flow cytometry devices are laser-based biophysical technology that are used for numerable functions namely, biomarker detection, cell counting, cell sorting, and protein engineering. This is done by suspending cells through a fluid stream and passing them through electronic detection apparatus. Flow cytometry is extensively used for the prognosis of health disorders, specifically blood cancer. It is also used for the clinical use during hematology, immunodeficiency, and organ transplant, which require accurate, sensitive, and quick diagnosis.

 View summary of this report, Click Here 

CytoFLEX LX is an addition to Beckman Coulter Life Sciences CytoFLEX platform.  Multi-parameter capabilities of its patented CytoFLEX flow cytometer technology posses 6 lasers and 21 fluorescent channels. This delivers many more parameters with the same unmatched fluoresce sensitivity and enhanced nanoparticle detection, which is required by the high end researchers.

The CytoFLEX LX is easy to use and maintain. It sets new standards of fluorescence sensitivity by reducing the loss of light to enable easy detection even to the dim populations. It can measure as low as 10 fluorescence molecules and measure particles that are as minute as 0.2 micrometers in size. Researchers can use this technology to measure 2 scatter parameters in addition to nearly 19 fluorescent markers, with 6 lasers, and providing 21 fluorescent channels. It offers highly sensitive and minute particle analysis in a bench-top analyzer. It has an extensive set of repositionable band pass filters flexibility to upgrade by adding extra parameters and intuitive software to improve multicolor analysis.

Once completely activated, the machine includes 3 florescent channels ranging from5 from the 405 nm (Violet) laser, 3 from the 375 nm (Near UV) laser, 3 from the 638 nm (Red) laser, 3 from 488 nm (Blue) laser, 3 from the 561 nm (Yellow) laser, and 2 from the 808 nm (Infrared) laser.

The flow cytometry market is expected to reach USD 8 billion by 2025; according to a new report by Grand View Research, Inc. demand for rapid, accurate, and sensitive diagnostic techniques and the prevalence of chronic diseases requiring toxicity tests can drive the market.

Agilent Technologies; Becton, Dickinson and Company; GE Healthcare; and Sysmex Corporation; are some key player of the flow cytometry.  The players participate in strategic partnership alliances and product development to get a competitive edge over the market.

Click Her For Access Full Report : https://goo.gl/FBTY3T

• Tweet
• Share
• Share
• Share
• Share

Related Post